Lyrica Capsule 75 mg (Pregabalin)

Adult dose

This drug is pregabalin, and the total daily dosage is divided into two doses taken orally, without regard to food. 1. Neuropathic Pain - Peripheral neuropathic pain: Starting dose of 150 mg per day, may increase to 300 mg daily after 3 to 7 days, and if necessary, can increase to a maximum of 600 mg daily at 7-day intervals. - Central neuropathic pain: Starting dose of 150 mg per day.

Child dose

The safety and efficacy data are insufficient for children under 12 years and adolescent patients aged 12-17, so administration is not recommended.

This medication may increase the risk of suicidal thoughts or behavior, so mood or behavior changes should be closely monitored during treatment. Pregabalin or any component of this drug should not be taken by individuals with allergies. This medication contains lactose and should not be administered to patients with certain genetic lactose intolerance. Diabetic patients may need to adjust their blood sugar control medications due to weight gain. If allergic reactions such as angioedema occur, the medication should be discontinued immediately. Elderly patients may need caution due to a risk of falls from dizziness or drowsiness. Blurred vision or changes in vision may occur and these symptoms may improve after stopping the medication. Withdrawal symptoms such as insomnia, headache, or anxiety may occur when discontinuing the drug, so it is recommended to taper off gradually. Due to the risk of drug abuse, patients with a history of mental illness or drug abuse should use this medication with caution. Patients with impaired renal function may need dose adjustment. Caution is needed for patients with heart disease, and there is an increased risk of central nervous system depression when used in combination with opioid analgesics. Patients with weakened respiratory function or elderly individuals should be careful as there is a risk of severe respiratory depression. In early pregnancy, there is a risk of fetal malformation, so it is advisable for pregnant women to avoid this medication and women of childbearing age should use effective contraception. Breastfeeding women should consider stopping breastfeeding or discontinuing the medication as it can be transferred through breast milk. This drug can cause dizziness and drowsiness, so caution should be exercised when driving or operating dangerous machinery. If severe skin reactions such as skin rash or Stevens-Johnson syndrome occur, stop taking the medication immediately and consult a healthcare professional. In the case of overdose, symptoms such as confusion, drowsiness, and seizures may occur, and immediate medical attention is necessary. Keep out of reach of children, and be cautious as transferring to another container can cause accidents.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, cold sweat, symptoms similar to anaphylaxis, skin and mucous membrane syndrome (Stevens-Johnson syndrome), erythema multiforme, toxic epidermal necrolysis, keratitis, congestive heart failure, pulmonary edema, tongue swelling, facial swelling, angioedema, severe allergic reactions, severe skin adverse reactions, respiratory problems, liver abnormality (jaundice), suicidal thoughts, suicidal behavior, loss of consciousness, mental disorders, paralysis (facial paralysis), serious

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 15 degrees Celsius and 30 degrees Celsius. Doing so will help maintain the drug's effectiveness.

Appearance

A hard capsule with a reddish-brown upper part and a white lower part containing white powder that is white or pale yellow.

Package unit

30 capsules/bottle